In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking
ConclusionThe core drug pair ofForsythiae Fructus-Lonicerae Japonicae Flos containing multiple components and targets is easy to combine with 3CLpro and ACE2, and exerts an anti-COVID-19 pneumonia effect through multi-component and multi-target, and plays the role of anti-COVID-19 pneumonia in multi-pathway.
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Chemistry | China Health | Complementary Medicine | Computers | Coronavirus | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Genetics | Herbs | Internal Medicine | Pneumonia | SARS